Persistent nephrolithiasis after discontinuation of indinavir therapy.
Polhemus
M E
ME
Department of Medicine, Walter Reed Army Medical Center, Washington, D.C. 20307, USA.
Aronson
N E
NE
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D007669:Kidney Calculi / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D019469:Indinavir